Secondary prevention of brain ischema;Sekundarpravention des ischamischen insults

Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung

Volumn 93, Issue 3, 1999, Pages 209-212

  Diener, Hans Christoph ^b   Kurth, Tobias ^b   Leonhardt, Georg ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

Anti platelet drugs; Anticoagulation; End arterectomy; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; PHENPROCOUMON; PLACEBO; TICLOPIDINE; ANTICOAGULANT AGENT;

ANTICOAGULATION; BRAIN ISCHEMIA; DRUG INDICATION; DRUG SAFETY; EMBOLISM; ENDARTERECTOMY; INTERNAL CAROTID ARTERY OCCLUSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK; BRAIN INFARCTION; CAROTID ENDARTERECTOMY; HUMAN; MULTIMODALITY CANCER THERAPY; RECURRENT DISEASE;

ANTICOAGULANTS; CEREBRAL INFARCTION; COMBINED MODALITY THERAPY; ENDARTERECTOMY, CAROTID; HUMANS; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RISK FACTORS;

EID: 0032990235     PISSN: 14317621     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Antiplatelet Trialists Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Brit Med J 308: 81-106
2. Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 154: 1449-1457
3. Barnett H, Kaste M, Meldrum H, Eliasziw M (1996) Aspirin dose in stroke prevention. Stroke 27: 588-592
4. Bower S, Sandercock P (1993) Antiplatelet and anticoagulant therapy. Curr Opinion Neurol 6: 55-59
5. Busch M, Masuhr F, Einhäupl KM (1997) Medical and surgical prevention of stroke: experiences around the world. Cerebrovasc Dis Suppl 1: 22-28
6. Caprie Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348: 1329-1339
7. Diener HC, Cuhna L, Forbes C, Sivenius J, Smets P, Lowenthal A (1996) European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143: 1-13
8. Diener HC, Forbes C, Riekkinen PJ, Sivenius J, Smets P, Lowenthal A, and the ESPS Group (1997) European stroke prevention study 2: Efficacy and safety data. J Neurol Sci 151: S1-S77
9. Dyken ML, Barnett HJM, Easton JD, Fields WS, Fuster V, Hachinski V, Norris JW, Sherman DG (1992) Low-dose aspirin and stroke: "It ain't necessarily so". Stroke 23: 1395-1399
10. EAFT Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342: 1255-1262
11. European Carotid Surgery Trialists Collaborative Group (1996) Endarterectomy for moderate symptomatic carotid stenosis: interim results from the MRC European carotid surgery trial. Lancet 347: 1591-1593
12. European Carotid Surgery Trialists' Collaborative Group (1991) MRC European carotid surgery trial: interim results for symptomatic patients with severe carotid stenosis and with mild carotid stenosis. Lancet 337: 1235-1243
13. Fuster V, Dyken ML, Vokonas PS, Hennekens C (1993) Aspirin as a therapeutic agent in cardiovascular disease. Circulation 87: 659-675
14. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, Panak E, Roberts RS, Sicurella J, Turpie AGG (1989) The Canadian American ticlopidine study (CATS) in thromboembolic stroke. Lancet i: 1215-1220
15. Hass WK, Easton JD, Adams HP, Pryse-Phillips W, Molony BA, Anderson S, Kamm B (1989) A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke. N Engl J Med 321: 501-507
16. North American Symptomatic Carotid Endarterctomy Study Group (1987) Carotid endarterctomy: three critical evaluations. Stroke 18: 987-989
17. Patrono C, Roth GJ (1996) Aspirin in ischemic cerebrovascular disease. Stroke 27: 756-760
18. The Dutch TIA Trial Study Group (1991) A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 325: 1261-1266
19. The ESPS Group (1987) The European Stroke Prevention Study (ESPS). Principal end-points. Lancet ii: 1351-1354
20. The SALT Collaborative Group (1991) Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 338: 1345-1349
21. UK-TIA Study Group (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatr 54: 1044-1954
22. Welty TE (1995) Cerebrovascular disorders. In: Young LE, Koda-Kimble MA (eds) Applied therapeutics: The clinical use of drugs. Applied Therapeutics. Vancouver, WA, 531-538
23. Wold PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 22: 983-988